About FDA
BLA Supplements MDUFMA FY 07
The vertical column graph presents standard and priority BLA efficacy supplements (combined) and BLA manufacturing supplements for FY 2003 through FY 2007. The vertical scale is in increments of 50 with a range from 0 to 150. The graph indicates that three BLA efficacy supplements were received in FY 2003, and then 0 from FY 2004 through FY 2007. The graph also indicates that the number of BLA manufacturing supplements, initially at 73 in FY 2003, decreased to 62 in FY 2004, decreased again to 25 in FY 2005, increased to 26 in FY 2006, and increased again to 148 in FY 2007.







